As posted on Linked In
Indicated Legal has made a detailed submission to the TGA’s consultation on the regulation of unapproved medicinal cannabis products.
Drawing on our experience working with clients across the medicinal cannabis sector, we propose a new national framework with three core priorities:
1. A dedicated ARTG registration pathway tailored to the complexity of cannabis medicines.
2. Robust enforcement of TGO 93 and GMP standards.
3. A clear focus on prescriber education and real-world evidence to support safe and effective use.
We also raise concerns about batch consistency limits for minor cannabinoids and SAS-B approvals for vape batteries.
We do not support broad restrictions on access through the SAS-B and AP schemes without a clear, accessible pathway to maintain patient continuity of care.
It was a pleasure to work with Daniel Rathner on this submission.
We welcome continued engagement with regulators and stakeholders to help shape the future of medicinal cannabis in Australia.
Sean Hocking
Source link